Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

3.310

+0.030 (0.91%)

Aug 14, 2025, 2:03 PM - Market open

Grace Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 14, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	46	31	32	21	54	120	Upgrade
Market Cap Growth	49.64%	-2.84%	56.90%	-62.03%	-55.00%	250.73%	Upgrade
Enterprise Value	26	20	7	-10	8	92	Upgrade
Last Close Price	3.28	2.28	3.42	2.76	7.32	28.80	Upgrade
PS Ratio	-	-	-	-	-	612.61	Upgrade
PB Ratio	0.71	0.47	0.52	0.30	0.50	2.16	Upgrade
P/TBV Ratio	3.19	1.81	2.58	1.10	2.12	2.16	Upgrade
EV/Sales Ratio	-	-	-	-	-	470.71	Upgrade
Debt / Equity Ratio	-	-	-	0.01	0.00	0.00	Upgrade
Asset Turnover	-	-	-	-	-	0.01	Upgrade
Quick Ratio	8.65	11.53	14.09	8.41	13.56	38.80	Upgrade
Current Ratio	8.87	11.77	14.26	8.59	13.89	39.50	Upgrade
Return on Equity (ROE)	-16.78%	-14.91%	-19.82%	-48.15%	-11.98%	-57.33%	Upgrade
Return on Assets (ROA)	-13.26%	-14.35%	-9.25%	-10.96%	-7.94%	-15.70%	Upgrade
Return on Capital (ROIC)	-15.05%	-16.24%	-10.83%	-12.86%	-9.23%	-19.45%	Upgrade
Earnings Yield	-22.60%	-30.59%	-39.92%	-206.80%	-18.17%	-16.39%	Upgrade
FCF Yield	-28.73%	-47.65%	-38.38%	-77.64%	-31.90%	-11.98%	Upgrade
Buyback Yield / Dilution	-28.20%	-26.85%	-28.16%	-21.09%	-148.46%	-40.25%	Upgrade

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q